Clinical Trials Directory

Trials / Sponsors / Alfasigma S.p.A.

Alfasigma S.p.A.

Industry · 21 registered clinical trials2 currently recruiting.

StatusTrialPhaseStarted
RecruitingA Study Evaluating the Effects of Filgotinib in Children and Teenagers With Ulcerative Colitis
Ulcerative Colitis
Phase 32025-09-29
RecruitingStudy to Measure Filgotinib in the Blood of Children and Teenagers With Arthritis Taking Filgotinib (SCALESIA)
Juvenile Idiopathic Arthritis
Phase 12024-05-13
Active Not RecruitingProspective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Coli
Ulcerative Colitis
2023-06-12
Active Not RecruitingA Study Evaluating the Effect of Filgotinib in Participants With Active Axial Spondyloarthritis
Axial Spondyloarthritis
Phase 32023-04-05
Active Not RecruitingProspective Observational Study of Filgotinib in Participants With Rheumatoid Arthritis in France
Rheumatoid Arthritis
2022-05-03
CompletedVelusetrag for the Treatment of Chronic Intestinal Pseudo-Obstruction (CIPO).
Chronic Intestinal Pseudo-obstruction
Phase 22021-12-15
CompletedSafety, Efficacy and Pharmacokinetics of Rifaximin in Patients With Moderate-to-severe Papulopustular Rosacea
Papulopustular Rosacea
Phase 22021-10-05
Active Not RecruitingProspective Observational Study of Filgotinib in Subjects With Rheumatoid Arthritis
Rheumatoid Arthritis
2021-05-11
TerminatedRifaximin Delayed Release for the Prevention of Recurrent Acute Diverticulitis and Diverticular Complications.
Diverticulitis
Phase 2 / Phase 32018-07-02
UnknownSafety and Efficacy of Rifaximin in Patients With Papulopustular Rosacea and Positive Lactulose Breath Test
Papulopustular Rosacea
Phase 22018-06-22
TerminatedA Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention
Crohn Disease
Phase 22017-11-16
TerminatedSafety, Tolerability, PK, Dosimetry, MTD and Preliminary Efficacy of Intra-lesionally Injected AvidinOX, Follo
Inoperable Solid Tumors or Lymphomas
Phase 12017-08-07
CompletedLong Term Extension Study to Assess the Safety and Efficacy of Filgotinib in Adults With Rheumatoid Arthritis
Rheumatoid Arthritis
Phase 32017-02-28
Active Not RecruitingFilgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Ulcerative Colitis
Phase 32017-02-23
UnknownA Trial to Evaluate the Efficacy and Safety of PMF104 Compared to a Conventional PEG-electrolyte Solution in C
Bowel Preparation Before Colonoscopy
Phase 32016-04-01
TerminatedEfficacy and Safety Study of Rifaximin Vaginal Tablets in Bacterial Vaginosis
BACTERIAL VAGINOSIS
Phase 22015-04-01
TerminatedEurartesim® in Patients With Imported Uncomplicated Plasmodium Vivax Malaria
Malaria, Vivax
Phase 22014-06-18
TerminatedAvidinOX + [177Lu]DOTA-biotin (or 177Lu-ST2210) Complex in Patients With Liver Metastases From Colorectal Canc
Liver Metastases
Phase 12013-11-11
CompletedSafety, Pharmacokinetics and Pharmacodynamics of Velusetrag in Healthy Elderly Subjects
Alzheimer's Disease
Phase 12011-11-01
CompletedPlacebo Controlled Study of 3 Doses of Rifaximin-EIR Tablet to Treat Moderate, Active Crohn's Disease
Crohn's Disease
Phase 22007-09-01
CompletedEvaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
Chronic Constipation
Phase 22006-10-01